← Leaderboards
Kazue Takahashi
Massachusetts General Hospital
$5,153,019
Attributed
$5,153,019
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2007–11$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$5,153,019 · 2
By mechanism
U01$4,678,473 · 1
R21$474,546 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Alan B Ezekowitz$3,996,778
- Edward T. Ryan$44,052,519
- Eric Franklin Grabowski$5,014,971
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenVirusInfluenza A VirusNovel TherapeuticsSerum ProteinsUptakeImmune SystemInfluenzaMannose Binding LectinMortality Vital StatisticsPhagocytosisProductionBaseBinding (Molecular Function)CytokineEpithelial CellsInfectionCellsIn VitroIn VivoMannose-Binding LectinsMorbidity - Disease RateComplementVirus Diseases
Grant awards (7)
Development of novel immunotherapy for influenza virus infection$929,766
U01 · FY2011 · AI · contact PI
Development of novel immunotherapy for influenza virus infection$937,230
U01 · FY2010 · AI · contact PI
Development of novel immunotherapy for influenza virus infection$919,127
U01 · FY2009 · AI · contact PI
Development of novel immunotherapy for influenza virus infection$892,349
U01 · FY2008 · AI · contact PI
Innate Immunity in the Clearance of Influenza A Virus Infected Apoptotic Cells$205,541
R21 · FY2008 · AI · contact PI
Development of novel immunotherapy for influenza virus infection$1,000,001
U01 · FY2007 · AI · contact PI
Innate Immunity in the Clearance of Influenza A Virus Infected Apoptotic Cells$269,005
R21 · FY2007 · AI · contact PI